-
Researcher uses HPV vaccine to treat patient with skin cancer
europeanpharmaceuticalreview
July 05, 2018
Evidence suggests the human papillomavirus plays a role in the development of some types of this skin cancer…
-
New hope for a syphilis vaccine
europeanpharmaceuticalreview
June 14, 2018
Researchers have identified exterior proteins on the bacteria that could serve as vaccine targets for syphilis.
-
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report
fiercepharma
June 13, 2018
Shingrix may not make it on the top 5 best-selling vaccines list in 2024...
-
Korea's GC Pharma establishes vaccine development firm in Seattle
biospectrumasia
May 28, 2018
The new company aims to bring together GC Pharma's commercial scale vaccine development expertise and deep understanding of protein science with IDRI and MIBR's world class scientific expertise in vaccine, adjuvant and formulation development
-
Cancer vaccine strategy blocks death of tumour-specific cytotoxic T cells
europeanpharmaceuticalreview
May 03, 2018
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking…
-
Manufacturing hiccup in China trips up Sanofi's vaccine sales momentum
fiercepharma
May 02, 2018
After a strong 2017, Sanofi Pasteur got off to a less-than-stellar start this year. In China, inspectors put a temporary kibosh on imports ...
-
Pfizer vaccine receives FDA's breakthrough therapy designation
biospectrumasia
April 26, 2018
As of 2016, the burden of MenB is highest in adolescents/young adults (32%) and infants (20%), followed by children ages 1 to 4 years (12%) and children ages 5 to 10 years (4%)
-
New vaccine could help people overcome cathinone abuse
europeanpharmaceuticalreview
April 24, 2018
Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones…
-
Vaccibody Moving Forward with Cancer Neoantigen Vaccine Trial
americanpharmaceuticalreview
April 19, 2018
PharmaJet announced Vaccibody AS has received approval to start their cancer neoantigen trial using the PharmaJet Stratis needle-free injection system.
-
Sanofi Pasteur’s vaccine facility to be set up in Toronto
expressbpd
April 19, 2018
Governments of Canada and Ontario have announced an investment of up to $70 million towards Sanofi Pasteur’s $500-million project